U.S. 8 Respiratory Diseases, 2019-2023: Supplier Shares and Country Segment Forecasts, 2019-2023

About This Report

This new 283-page report presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs.

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used 
   for microbiology testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies, 
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as ’s proprietary data files was conducted.



Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests

1. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
(continued)
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
IX. USA: Market Size, Growth and Major Suppliers
Sales and Market Shares
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
(continued)
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List Of Tables


Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Tuberculosis Tests
U.S.A.
Adenovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Adenovirus Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Influenza Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Influenza Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Legionella Test Volume and Diagnostics Sales Forecast
by Market Segment

U.S.A.
Legionella Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Mononucleosis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Mononucleosis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Mycoplasma Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Mycoplasma Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Pneumonia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Pneumonia Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
RSV Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
RSV Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Tuberculosis Test Volume and Diagnostics Sales Forecast
by Market Segment

U.S. Infectious Disease Testing Market for Over 100 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

LeadingMarketResearch.coms new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends;

USD 4850 View Report

U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing, 2019-2023: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new study from  contains 430 pages, and is designed to help

USD 2450 View Report

U.S. 8 Sexually-Transmitted Diseases (STD): Supplier Shares and Country Forecasts, 2019-2023

About This ReportThis new 280-page report presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,

USD 2450 View Report

U.K. 8 Respiratory Diseases, 2019-2023: Supplier Shares and Country Segment Forecasts, 2019-2023

About This ReportThis new 281-page report presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and

USD 1950 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available